Highlights
IIA supported (ever)1 patent
About
Genetic Treatment for Age-related Diseases
SirTLab is the leader in Restoring SIRT6 Expression for Severe Liver Diseases and Diseases of Aging.
Sirtuin 6 (SIRT6) is a Key Regulator for Health in all cells. Levels of SIRT6 are reduced in liver diseases: NASH1, other cirrhosis, metabolic syndrome, acetaminophen toxicity.
SIRTLab patented SIRT6-mRNA-LNP2 for liver specific expression of SIRT6 is based on 18 years of research.
Identity
| Name | SirTlab Corporation |
|---|---|
| Slug | sirtlab-corporation |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoInB6YMJDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ramat Gan |
| HQ address | Ramat Gan, Israel |
Web & social
| Website | https://www.sirtlabcorp.com/ |
|---|---|
| https://www.facebook.com/Sirtlab-Corporation-292940321216684 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2BB2C
Tags
anti-agingtherapeuticspharmaceuticalsgeneticspharma-companieschronic-patients
Funding
| Total raised | $1.5M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}